|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating expenses: | |||||
| Research and development (including related party amounts of $915 and $891, respectively) | |||||
| General and administrative (including related party amounts of $528 and $537, respectively) | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income, net | |||||
| Interest income | |||||
| Net loss | |||||
| Net loss per share, basic | |||||
| Net loss per share, diluted | |||||
| Weighted-average shares of common stock outstanding, basic | |||||
| Weighted-average shares of common stock outstanding, diluted | |||||
Loading...
